Descriptive statistics of morbidity and coronary revascularisation characteristics of individuals with a diagnosis of AMI from inpatient care in 2008–2010 in Sweden (n=10 225)
| Characteristics of patients with AMI | All | Women | Men | Pearson’s χ2 (p value) |
| n (%) 10 225 (100) | n (%) 2341 (22.9) | n (%) 7884 (77.1) | ||
| Morbidity characteristics | ||||
| Inpatient care due to AMI, days (median: 3 days)** | ||||
| No inpatient care | 777 (7.6) | 180 (7.7) | 597 (7.6) | 6.0 (0.05) |
| 1–3 days | 5743 (56.2) | 1265 (54.0) | 4478 (56.8) | |
| >3 days | 3705 (36.2) | 896 (38.3) | 2809 (35.6) | |
| Type of infarction*,** | ||||
| STEMI | 3584 (35.1) | 663 (28.3) | 2921 (37.1) | 68.0 (<0.01) |
| NSTEMI | 4597 (45.0) | 1205 (51.5) | 3392 (43.0) | |
| Unspecified | 2044 (20.0) | 473 (20.2) | 1571 (19.9) | |
| Somatic comorbidity† | ||||
| Musculoskeletal disorders‡,** | ||||
| Yes | 1519 (14.9) | 449 (19.2) | 1070 (13.6) | 44.9 (<0.01) |
| No | 8706 (85.1) | 1892 (80.8) | 6814 (86.4) | |
| Diabetes mellitus**,‡, § | ||||
| Yes | 1584 (15.5) | 398 (17.0) | 1186 (15.0) | 5.3 (<0.05) |
| No | 8641 (84.5) | 1943 (83.0) | 6698 (85.0) | |
| Renal insufficiency‡ | ||||
| Yes | 142 (1.4) | 40 (1.7) | 102 (1.3) | 2.3 (0.13) |
| No | 10 083 (98.6) | 2301 (98.3) | 7782 (98.7) | |
| Hypertension**,‡ | ||||
| Yes | 3236 (31.7) | 805 (34.4) | 2431 (30.8) | 10.5 (<0.01) |
| No | 6989 (68.4) | 1536 (65.6) | 5453 (69.2) | |
| Stroke‡ | ||||
| Yes | 106 (1.0) | 24 (1.0) | 82 (1.0) | 0.004 (0.95) |
| No | 10 119 (99.0) | 2317 (99.0) | 7802 (99.0) | |
| Cancer**,‡ | ||||
| Yes | 506 (5.0) | 170 (7.3) | 336 (4.3) | 34.5 (<0.01) |
| No | 9719 (95.1) | 2171 (92.7) | 7548 (95.7) | |
| Other somatic disorders**,‡ | ||||
| Yes | 6706 (65.6) | 1690 (72.2) | 5016 (63.6) | 58.7 (<0.01) |
| No | 3519 (34.4) | 651 (27.8) | 2868 (36.4) | |
| Mental comorbidity | ||||
| Mental disorders**,†‡ | ||||
| Common mental disorders | 444 (4.3) | 146 (6.2) | 298 (3.8) | 26.4 (<0.01) |
| Other mental disorders | 911 (8.9) | 199 (8.5) | 712 (9.0) | |
| No | 8870 (86.8) | 1996 (85.3) | 6874 (87.2) | |
| Antidepressants**,¶ | ||||
| Small doses | 420 (4.1) | 163 (7.0) | 257 (3.3) | 241.0 (<0.01) |
| Moderate doses | 623 (6.1) | 262 (11.2) | 361 (4.6) | |
| High doses | 272 (2.7) | 94 (4.0) | 178 (2.3) | |
| No antidepressants | 8910 (87.1) | 1822 (77.8) | 7088 (89.9) | |
| Anxiolytics**,¶ | ||||
| Small doses | 606 (5.9) | 228 (9.7) | 378 (4.8) | 120.4 (<0.01) |
| Moderate doses | 134 (1.3) | 51 (2.2) | 83 (1.1) | |
| High doses | 81 (0.8) | 35 (1.5) | 46 (0.6) | |
| No anxiolytics | 9404 (92.0) | 2027 (86.6) | 7377 (93.6) | |
| Sedatives**,¶ | ||||
| Small doses | 573 (5.6) | 192 (8.2) | 381 (4.8) | 118.5 (<0.01) |
| Moderate doses | 362 (3.5) | 137 (5.9) | 225 (2.9) | |
| High doses | 195 (1.9) | 73 (3.1) | 122 (1.6) | |
| No sedatives | 9095 (89.0) | 1939 (82.8) | 7156 (90.8) | |
| Coronary revascularisation characteristics**, * | ||||
| PCI | 7224 (70.7) | 1356 (57.9) | 5868 (74.4) | 275.1 (<0.01) |
| CABG | 207 (2.0) | 32 (1.4) | 175 (2.2) | |
| Others | 2794 (27.3) | 953 (40.7) | 1841 (23.4) | |
*Measured at the date of AMI.
†Measured during 3 years before the date of AMI.
‡Measured by main or side diagnosis in inpatient or specialised outpatient care.
§Measured by medication for diabetes mellitus.
¶Measured during the year preceding AMI.
**Significant sex differences.
AMI, acute myocardial infarction; CABG, coronary artery bypass grafting; PCI, percutaneous coronary intervention; NSTEMI, non-ST-elevation myocardial infarction; STEMI, ST-elevation myocardial infarction.